RxDoctor Payments Data

Richard Gilbert, MD

Family Medicine · Burlington, NCNPI 1336230747

Payments from drug & device makers

$5,270in general payments, 2019–2025

Across 335 payments — averaging $15.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$719
  • Boehringer Ingelheim$713
  • Novo Nordisk$604
  • Lilly USA, LLC$306
  • AbbVie$201
  • Merck$186
  • plus $3K from 41 others

What the payments were for

  • Food & beverage$5,22499%
  • Education$471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,270 in reported general payments places this provider in the 90th percentile of 3,444 family medicine providers in North Carolina.

See all family medicine providers in North Carolina

Medicare billing

Part B allowed, 2024
$54,635
Medicare patients
109
Services billed
1,285

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin52$54,182
OzempicSemaglutide44$53,095
EliquisApixaban40$40,880
TrulicityDulaglutide40$36,897
MounjaroTirzepatide18$27,111
FarxigaDapagliflozin Propanediol17$23,784
XareltoRivaroxaban20$14,664
LinzessLinaclotide20$12,508
PaxlovidNirmatrelvir/Ritonavir12$5,628
Dexlansoprazole DrDexlansoprazole15$4,360
Rosuvastatin Calcium251$3,967
Omeprazole182$3,581
DexilantDexlansoprazole11$3,192
Gabapentin137$2,994
Levothyroxine Sodium213$2,652

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$306$64,00858 claims
Boehringer IngelheimJardiance$713$54,18252 claims
Novo NordiskOzempic$604$53,09544 claims
PfizerEliquis, Paxlovid$72$46,50852 claims
AstraZenecaFarxiga$719$23,78417 claims
Johnson & JohnsonXarelto$48$14,66420 claims
AbbVieLinzess, Synthroid$201$13,60836 claims
Takeda Pharmaceuticals U.S.A., Inc.Dexilant$113$3,19211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,444 family medicine providers in North Carolina.

Other family medicine in Burlington

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →